EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) belongs to Healthcare sector. Its weekly performance is 20.00%. On last trading day company shares ended up $7.38. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) distance from 50-day simple moving average (SMA50) is 23.41%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) and Polpharma Group announced the signing of a multi-product, multi-region profit-sharing collaboration for select EPIRUS biosimilars, including BOW015 (infliximab, reference biologic Remicade®), BOW050 (adalimumab, reference biologic Humira®) and BOW070 (tocilizumab, reference biologic Actemra®), representing $6 billion in innovator sales in the specified territoriesi.
FormFactor Inc. (NASDAQ:FORM) shares moved down -9.97% in last trading session and ended the day at $7.77. FORM Gross Margin is 31.00% and its return on assets is -1.70%. FormFactor Inc. (NASDAQ:FORM) quarterly performance is -18.30%. FormFactor, Inc. (NASDAQ: FORM) will report financial results for its 2015 fiscal second quarter on Wednesday, July 29, 2015, at 1:30 p.m. Pacific Daylight Time.
On 14 July, Zhaopin Ltd. (NYSE:ZPIN) shares moved down -2.23% and was closed at $14.92. Zhaopin Ltd. (NYSE:ZPIN) year to date (YTD) performance is -1.71%. Analysts at Citigroup Inc. started coverage on shares of Zhaopin (NYSE:ZPIN) in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $20.30 price target on the stock. Citigroup Inc.’s price target would indicate a potential upside of 23.93% from the company’s current price.
Optical Cable Corp. (NASDAQ:OCC) ended the last trading day at $3.53. Company weekly volatility is calculated as 1.91% and price to cash ratio as 35.70. Optical Cable Corp. (NASDAQ:OCC) showed a weekly performance of 0.86%. Optical Cable Corp. (NASDAQ: OCC) announced that the Company’s Board of Directors has approved a plan to purchase and retire up to 400,000 shares of OCC’s common stock, or approximately 6 percent of the current shares outstanding. OCC anticipates that the purchases will be made during the next 24 to 36 months.
Johnson & Johnson (NYSE:JNJ) shares decreased -0.49% in last trading session and ended the day at $99.78. JNJ Gross Margin is 69.30% and its return on assets is 15.70%. Johnson & Johnson (NYSE:JNJ) quarterly performance is -0.01%. Johnson & Johnson (NYSE:JNJ) posted quarterly net earnings of $4.52 billion, or $1.61 per share, compared to $4.33 billion, or $1.51 per share, in the year-ago quarter. Excluding non-recurring items, the company’s adjusted earnings came in at $1.71 per share.